Events

Calling pre-seed and seed innovators and entrepreneurs in Oncology, Cell & Gene Therapy, Cardiovascular, Immunology, Radiology, and Digital Health!

Do you have disruptive science but struggle to bring it to life in the entrepreneurial world? Bayer's passion is to enable and support standout healthcare innovation.

Take your innovation to new heights and join Bayer's Expert Mondays 2024, a series of knowledge exchange sessions to supercharge your startup’s growth.

Each one-hour Bayer's Expert Monday includes a live Q&A with respective Bayer Experts. You can stay for a Meet & Greet with Bayer Scouts and Scientific Finders. Please reserve 30 additional minutes in your schedule for the Meet & Greet after the Bayer Expert session.

These sessions are not intended for service providers, consultants, IT providers, etc. They are designed for drug developers and healthcare researchers seeking collaboration with big pharma and out-licensing opportunities later in their journey. Session recordings are NOT distributed afterward. Live attendance is necessary to get the most out of the expert sessions and network with the Bayer Pharma team.

The Jun 24 event features Sebastian Karrer, Head of BD&L EMEA CtC Hub EMEA and Tanja Bloser, Ecosystem Activation, CtC Hub EMEA. Reserve your spot here. 

Join Osage University Partners (OUP) for a two-part webinar series on finding a CEO for your academic startup company. We will hold the first part of this webinar series on June 21st and will focus on the evaluation process for CEO candidates. OUP Managing Partner Marc Singer will discuss the importance of the leadership team to a startup’s success and explore methods for evaluating outside CEOs. The webinar will highlight relevant backgrounds and important characteristics of a startup CEO, and it will provide tools to assist with candidate evaluation. Marc will also provide data on the performance of different types of CEOs, including grad students and professors, from OUP’s tech portfolio.

The second part of the webinar series will be held later this summer and will focus on sourcing of the CEO and other C-suite talent. OUP Managing Partner Matt Cohen will moderate a panel featuring a recruiter, a talent professional from a VC firm, and a serial academic entrepreneur. Dates and additional information coming soon.

Register here. 

NCI SBIR Program director Saroj Regmi will be hosting a virtual Q&A session on the Small Business Transition Grant. Following a brief overview on this funding opportunity, Saroj will answer attendee questions.

The Small Business Transition Grant was developed to assist early-career academic scientists in transitioning to entrepreneurship. Beginning as a Phase I STTR award that transitions into a Phase II SBIR award, it provides innovators with up to $2.4 million towards their biotech R&D efforts. As of this year’s Notice (RFA-CA-24-023), the Small Business Transition Grant has also expanded to include a Phase I STTR-only option. Applications are due Monday, August 21, 2024 by 5:00 p.m. ET.

Join Saroj's virtual webinar to learn more. 

The Antibody and Bioresource Core Facility (ABCF) supports researchers by making it easier for them to develop new monoclonal antibodies (MAbs). As an informational resource as well as service provider, the facility collaborates closely with faculty from MSK and Rockefeller University. It also supports Weill Cornell Medicine researchers as third-party clients.

Attend this virtual interview to discover more about the core facility and how it can support your project. The 45-min interview will be followed by a 15-minute Q&A session for the audience.

Join us to discover ABCF’s resources and capabilities, including:

• Generating custom MAbs
• Distributing cell lines and hybridomas developed at MSK and RU
• Performing mycoplasma testing

Interviewers

Loren A. Busby, CFA, Director, Weill Cornell Medicine BioVenture eLab

Carlo Yuvienco, PhD, Director, Ford Center Incubator @ The Rockefeller University

Featured Guest

Frances Weis-Garcia, PhD ’96, Director, Bi-Institutional Antibody and Bioresource Core Facility

Register here. 

Making a change to pursue your dream, turn an idea into a business, and go for it is scary. How have others taken the leap? Hear from a live panel of Cornellians who made the career transition to entrepreneurship. Learn about where they started, their practical and personal processes, and where they are now.

Join us for a networking reception, panel discussion with audience Q&A, and CEN’s trademark “Open Mic,” where YOU can give your 30-second elevator pitch. What better way to start your entrepreneurial journey?!

Featuring:

• Chris Donohoe ’09, Executive Coach (moderator)
• Marissa Saporta ’99, Co-Founder of Gorilla Commerce
• Siwat Siengsanaoh MBA ’15, Co-Founder, Recoup Beverage, Inc.
• Lauren Berson ’04, CEO & Co-Founder, Conceive

Register now. 

Back by popular demand and with the specific aim to cover more intermediate biodesign concepts, this workshop will teach you techniques to generate ideas and physical prototypes for medical device products and education models.

Building on prior 3D printing classes, this program will cover:

• Biodesign concepts to generate ideas
• Expanded 3D printing applications
• Q&A with speakers

Speakers:

NatalieDeana Badillo: 3rd year medical student at Weill Cornell Medicine who possesses a biomedical engineering background. Natalie is also a member of the Biomedical Engineering Society and is President of the Arts & Crafts & 3D Printing Club at Weill Cornell Medicine.

Ana Krieger, M.D., MPH: Chief of Sleep Neurology and Professor of Clinical Medicine in the Departments of Medicine, Neurology and Genetic Medicine at Weill Cornell Medicine. Dr. Krieger is also Co-Founder of BioSleep Technologies and is an experienced user of WCM’s biodesign/3D printing resources.

Register here. 

There’s a lot of buzz these days around the role that AI will play in pharmaceutical R&D – from target identification to therapeutic design and optimization, from patient stratification to clinical trial design and site selection, and beyond.

So what’s real, and what’s just hype?

Join JLABS for an engaging panel discussion – featuring representatives from the pharmaceutical industry, the startup world and the investor community – focused on how AI is driving the discovery, development and delivery of innovative medicines today, and what the future holds in this rapidly-evolving space. Followed by an exciting celebratory reception to commemorate JLABS at NYC Six-Year Anniversary!

RSVP here. 

Led by the NSF I-Corps Hub: Interior Northeast (IN I-Corps), these free NSF I-Corps Regional Courses are designed for university-based STEM researchers and early-stage founders interested in evaluating the market potential of their technology and learning valuable entrepreneurial skills.

In this month-long virtual course (July 8 - August 7), researchers working on a deep tech innovation “get out of your comfort zone” and talk with customers (virtually) to identify the best product-market fit. 

Applications will be reviewed on a rolling basis. Apply now. 

Application closes on Wednesday, June 12. Questions? Contact icorps@cornell.edu or visit www.in-icorps.org/regional-courses. 

Invent Together presents a virtual discussion with Erin Kelley, Genna Hibbs, and Maria Artunduaga on the importance of building your innovation support network and tips to succeed. Register here. 

Join the greater Weill Cornell Medicine community for the $100K Biomedical Business Plan Challenge Pitch Event. Faculty-led startups will have completed 10 weeks of rigorous instruction by life science professionals and, with the help of over two dozen industry mentors, created their initial business plans. This event provides an opportunity for the BPC startup teams to pitch their ideas to a group of prominent venture capital judges and compete for up to $100,000 in prize money.

We will kick off the evening at 5:30pm in Uris Auditorium, followed by a celebration of academic entrepreneurship and innovation in Griffis Faculty Lounge. Register here.